Stop-and-watch strategy after cessation of nucleos(t)ide analogue therapy in HBeAg-negative patients

J Hepatol. 2018 May;68(5):1102-1104. doi: 10.1016/j.jhep.2017.12.031. Epub 2018 Feb 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens*
  • Hepatitis B, Chronic*
  • Humans
  • Tenofovir

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Tenofovir